⌕
Neurocrine Biosciences · NBIX · Nasdaq
Tenet 65 · Solid
Compare
$165.31−1.25%At closeTenet 65 · Solid
$165.31−2.09 (−1.25%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Neurocrine Biosciences (NBIX) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice

7 figures withheld by our checks. Each blank figure names its reason.

62
VALUE
Fairly priced
in line with its peers
75
QUALITY
Elite
top-decile economics
59
HEALTH
Stable
manageable balance sheet
66
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

An elite business at a fair price: value 62, quality 75, health 59, growth 66, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
62nd pctilein line with its peers
Earnings yield (EBIT/EV)EBIT (operating income) for the latest fiscal year ÷ enterprise value on the current market cap (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.5.5%73rd pctile
P/E25.162nd pctile
P/B4.450th pctile
P/FCF16.371st pctile
EV / EBITDA16.656th pctile
59th pctilemanageable balance sheet
Current ratio2.0434th pctile
Quick ratio(Cash, short-term investments and receivables) ÷ current liabilities, as the data vendor builds it. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.1.7242nd pctile
Net debt / EBITDADebt less cash and all investments, including long-term stakes, over EBITDA, as the data vendor builds it−0.8×71st pctile
Interest coverage—Not measured: there is no interest expense on file.
Debt / equity0.0087th pctile
75th pctiletop-decile economics
ROIC17%87th pctile
ROE20%82nd pctile
Gross margin98.7%97th pctile
Net margin19.0%84th pctile
Income quality (CFO/NI)1.52×48th pctile
Piotroski F5 / 949th pctileown record too short
Altman Z7.474th pctile
66th pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin28.1%93rd pctile
the receipts behind the numbers above
Greenblatt earnings yield5.5%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC17%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 313 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 13, 2026 · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.